meta_pixel
Tapesearch Logo
Log in
PBS News Hour - Segments

Leading researcher explains how viewing addiction as a brain disorder improves treatments

PBS News Hour - Segments

PBS NewsHour

News, Daily News

4.11K Ratings

🗓️ 19 December 2024

⏱️ 7 minutes

🧾️ Download transcript

Summary

This week, we are reporting on some promising treatments for two of the deadliest drugs in America: opioids and alcohol. William Brangham sat down with one of the nation's leading researchers who is studying America's addictions and how we can better address them. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Transcript

Click on a timestamp to play from that location

0:00.0

This week we've been reporting on some promising treatments for two of the deadliest drugs in America, opioids and alcohol.

0:07.0

William Brangham is back now with a conversation with one of the nation's leading researchers who is studying America's addictions and how we can better address them.

0:15.0

My next guest is one of the researchers who helped establish that addiction is in fact a brain disorder,

0:22.5

that taking certain drugs over time can change how our brains actually work.

0:28.4

Dr. Nora Volkov is the head of the National Institute on Drug Abuse, which is part of the NIH,

0:34.2

and is one of the world's biggest funders of research into drug abuse and addiction.

0:39.3

Dr. Volkov, so good to have you on the program.

0:42.6

We have been reporting on a few of the medications that show effectiveness for treating opioids

0:49.1

and alcohol abuse disorders.

0:51.5

And I wonder that from your long research on this topic, what role do you

0:56.4

see medications playing and helping people address their addictions? In the case of opioid juice disorders,

1:04.6

they're being crucial and they've been lifesaving. And again, it's one of the drivers that is now

1:09.4

reducing the number of people that are dying.

1:12.6

So in the case of opioid addiction, we have very effective medications.

1:17.3

The problems are, number one, that only a small percentage of people that would benefit from them,

1:22.4

approximately 25%, will get prescribed this medication.

1:26.8

Second problem is they start taking them and that protects them from overdosing,

1:31.3

but at six months, 50% of them will stop taking their medications.

1:36.3

And we only have three.

1:37.3

Bubrenorphine, methadone, and naltrexone.

1:40.3

So we need a wider variety of medication, and we need alternatives so that people that don't

1:46.3

respond to one medication can have options that go beyond those three medications.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from PBS NewsHour, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of PBS NewsHour and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.